DEPLOYDatabase

Company

Cognixion

Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality.

HQ
Santa Barbara, California, USA
Status
Private

CategoryBiometric wearables

Overview

Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality. Its Cognixion ONE Axon-R headset combines BCI, AI, and AR for communication in patients with ALS and severe motor impairment. FDA Breakthrough Device Designation (May 2023). Clinical trial launched for late-stage ALS. $25M raised to date. Named Wearable & Implantable Technology of the Year at MedTech World 2026.

Reality check

Product (company-claimed)

Cognixion ONE Axon-R: non-invasive wireless EEG BCI headset with an integrated AR display and AI.

FDA status (company-claimed, May 2023)

Breakthrough Device designation.

Verified record

Verified deployments
2 deployments on file
Active incidents
None on file

Key facts

Clinical trials (reported, unconfirmed)

NCT06810219 (ALS, 2025) and NCT07209943 (ALS, stroke and TBI with Vision Pro, Oct 2025).

Collaborators (reported, unconfirmed)

Johns Hopkins, Mass General, Northwell Health, Memorial Hermann and the VA.

Data & sources

Press releases

1

1 source backing this record.View all →

Current leadership (2)

Founders (1)

See all founders across the registry →

Safety record

No incidents on record for Cognixion.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operator customers (1)

Recent coverage

Cognixion in third-party press

Peer companies

Mentioned on (2)

Registry pages whose text names Cognixion.